?

Ryan Arthur F

Director
Regeneron Pharmaceuticals, Inc.
US, Tarrytown [HQ]
CIK 1187443

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
18,280
Price per Share :
$703.43
Equivalence :
$12,858,700.40

Transaction History

  • S
    Form 4
    18,280 Shares After Transaction
    Value : $17,508,218.40
    Sold $1,915.56
    04/01/24
  • Footnotes:
    #1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.
    #2 Represents volume-weighted average price of sales of 9 shares of Company stock on April 1, 2024 at prices ranging from $959.13 to $959.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price.
    #3 Represents volume-weighted average price of sales of 15 shares of Company stock on April 1, 2024 at prices ranging from $960.06 to $960.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price.
  • S
    Form 4
    18,278 Shares After Transaction
    Value : $17,526,043.08
    Sold $1,917.72
    04/01/24
  • S
    Form 4
    18,269 Shares After Transaction
    Value : $17,528,557.43
    Sold $8,635.23
    04/01/24
  • S
    Form 4
    18,254 Shares After Transaction
    Value : $17,533,514.62
    Sold $14,407.95
    04/01/24
  • S
    Form 4
    18,240 Shares After Transaction
    Value : $17,539,401.60
    Sold $13,462.26
    04/01/24

Get PRO Today.

PRO unlocks 173 more insider transactions made by Ryan Arthur F

Start Free PRO trial Subscribe to PRO